Report date: Nov 6,2024
Conflict count: 361874
Publisher: Silicea - Poligraf, LLC
Title count: 2
Conflict count: 26


==========================================================

Created: 2022-04-07 06:34:59
ConfID: 6464429
CauseID: 1526000601
OtherID: 1522184385
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Yavelov,21,2,3196,2022,Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial
DOI: 10.15829/1728-8800-20223196(Journal) (6464429-N)
DOI: 10.15829/1728-8800-2022-3196(Journal)
==========================================================

Created: 2018-05-11 08:34:05
ConfID: 5369475
CauseID: 1425715552
OtherID: 1398449418
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Budnevsky,15,5,97,2016,The role of melatonin in pathogenesis of cardiovascular diseases
DOI: 10.15829/1728-8800-2016-5-69-73(Journal) (5369475-N)
DOI: 10.15829/1728-8800-2016-5-97-101(Journal)
==========================================================

Created: 2020-03-23 12:50:54
ConfID: 5584071
CauseID: 1465525729
OtherID: 1457432667
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Postol,18,5,38,2019,Analysis of arrhythmic episodes in patients with implanted cardioverter defibrillators and a high risk of sudden cardiac death
DOI: 10.15829/38-46(Journal) (5584071-N)
DOI: 10.15829//1728-8800-2019-5-38-46(Journal)
DOI: 10.15829/1728-8800-2019-5-38-46(Journal)
==========================================================

Created: 2018-05-11 08:34:05
ConfID: 5369476
CauseID: 1425715552
OtherID: 1398449418
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Golovanova,15,5,79,2016,Risk factors and longevity
DOI: 10.15829/1728-8800-2016-5-(Journal) (5369476-N)
DOI: 10.15829/1728-8800-2016-5-79-83(Journal)
==========================================================

Created: 2016-05-19 06:26:43
ConfID: 5100049
CauseID: 1392951147
OtherID: 1392785880
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Koziolova,15,2,83,2016,Approaches to anticoagulation therapy selection in patients with non-valvular atrial fibrillation and ischemic heart disease
DOI: 10.15829/1728-8800-2016-1-(Journal) (5100049-N)
DOI: 10.15829/1728-8800-2016-2-83-92(Journal)
==========================================================

Created: 2016-05-19 06:26:43
ConfID: 5100050
CauseID: 1392951147
OtherID: 1392785880
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Vasyuk,15,2,4,2016,Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice
DOI: 10.15829/1728-8800-2016-2-(Journal) (5100050-N)
DOI: 10.15829/1728-8800-2016-2-4-19(Journal)
==========================================================

Created: 2020-03-19 09:48:37
ConfID: 5583349
CauseID: 1465345078
OtherID: 1464929374
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Zagrebelny,19,1,62,2020,Factors associated with in-hospital mortality in patients after acute cerebrovascular accident (according to the REGION-M register)
DOI: 10.15829/1728-8800-2020-1-62-69(Journal) (5583349-N)
DOI: 10.15829/1728-8800-2020-1-2443(Journal)
==========================================================

Created: 2020-03-19 09:48:37
ConfID: 5583348
CauseID: 1465345078
OtherID: 1464929374
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Kontsevaya,19,1,48,2020,Economic damage of risk factors associated with morbidity and mortality from major chronic non-communicable diseases in Russia in 2016
DOI: 10.15829/1728-8800-2020-1-2396(Journal) (5583348-N)
DOI: 10.15829/1728-8800-2020-1-48-55(Journal)
==========================================================

Created: 2020-03-19 09:48:37
ConfID: 5583350
CauseID: 1465345078
OtherID: 1464929374
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Sayutina,19,1,106,2020,Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits
DOI: 10.15829/1728-8800-2020-1-106-117(Journal) (5583350-N)
DOI: 10.15829/1728-8800-2020-1-2453(Journal)
==========================================================

Created: 2019-03-11 09:17:11
ConfID: 5458550
CauseID: 1440984853
OtherID: 1396566431
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Kireev,15,4,16,2016,NOVEL DIRECTION IN MYOCARDIAL INFARCTION PREVENTION — ACCENT ON MEDICAL AND SOCIAL CHARACTERISTICS OF PATIENT
DOI: 10.15829/1728-8800-2016-4-(Journal) (5458550-N)
DOI: 10.15829/1728-8800-2016-4-16-21(Journal)
==========================================================

Created: 2019-09-21 04:36:45
ConfID: 5527666
CauseID: 1454609872
OtherID: 1439741290
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Vilkov,17,4,67,2018,Obesity trends in populations of the Russian Federation and the United States of America. Thirty-year long dynamics
DOI: 10.15829/1728-8800-2018-4-67-73(Journal) (5527666-N)
DOI: 10.15829/1728-8800-2018-4-67-72(Journal)
==========================================================

Created: 2020-03-19 09:48:37
ConfID: 5583346
CauseID: 1465345078
OtherID: 1464929374
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Churilin,19,1,17,2020,Apolipoprotein E gene polymorphisms: a relationship with the risk of coronary artery disease and the effectiveness of lipid-lowering therapy with rosuvastatin
DOI: 10.15829/1728-8800-2020-1-2297(Journal) (5583346-N)
DOI: 10.15829/1728-8800-2020-1-17-23(Journal)
==========================================================

Created: 2022-09-19 07:22:42
ConfID: 6594771
CauseID: 1542099658
OtherID: 1541001806
JT: CARDIOVASCULAR THERAPY AND PREVENTION
MD: Kiselev,21,8,3306,2022,Physiological and pathophysiological aspects of short-term middle-altitude adaptation in humans
DOI: 10.15829/1728-8800-20223306(Journal) (6594771-N)
DOI: 10.15829/1728-8800-2022-3306(Journal)